172 related articles for article (PubMed ID: 6851195)
1. The renin-angiotensin system and total body sodium and potassium in hypertensive women taking oestrogen-progestagen oral contraceptives.
McAreavey D; Cumming AM; Boddy K; Brown JJ; Fraser R; Leckie BJ; Lever AF; Morton JJ; Robertson JI; Williams ED
Clin Endocrinol (Oxf); 1983 Feb; 18(2):111-8. PubMed ID: 6851195
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptives--induced hypertension--nine years later.
Laragh JH
Am J Obstet Gynecol; 1976 Sep; 126(1):141-7. PubMed ID: 961741
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced hypertension: pathogenesis and management.
Stokes GS
Drugs; 1976; 12(3):222-30. PubMed ID: 185040
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
5. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women.
Weinberger MH; Kramer NJ; Grim CE; Petersen LP
J Clin Endocrinol Metab; 1977 Jan; 44(1):69-77. PubMed ID: 833263
[TBL] [Abstract][Full Text] [Related]
6. Renal blood flow and its response to angiotensin II. An interaction between oral contraceptive agents, sodium intake, and the renin-angiotensin system in healthy young women.
Hollenberg NK; Williams GH; Burger B; Chenitz W; Hoosmand I; Adams DF
Circ Res; 1976 Jan; 38(1):35-40. PubMed ID: 1244226
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin II analog on blood pressure, renin and aldosterone in women on oral contraceptives and toxemia.
Saruta T; Nakamura R; Nagahama S; Suzuki H; Kondo K
Gynecol Obstet Invest; 1981; 12(1):11-20. PubMed ID: 7019015
[TBL] [Abstract][Full Text] [Related]
8. [Changes of the renin-angiotensin-aldosterone system under contraceptive steroids. Contribution to the etiology of hypertension under hormonal contraceptives].
Kaulhausen H; Klingsiek L; Breuer H
Fortschr Med; 1976 Nov; 94(33):1925-30. PubMed ID: 186375
[TBL] [Abstract][Full Text] [Related]
9. [Clinical aspects of hypertension under contraceptive steroids].
Kaulhausen H; Klingsiek L
Fortschr Med; 1976 Dec; 94(34):2005-13. PubMed ID: 793966
[TBL] [Abstract][Full Text] [Related]
10. Hypertension and oral contraceptives.
Broughton Pipkin F; Hunter JC; Oats J; Symonds M
Br Med J; 1978 Jul; 2(6132):278. PubMed ID: 678905
[No Abstract] [Full Text] [Related]
11. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
[TBL] [Abstract][Full Text] [Related]
12. [Hormonal contraception and hypertension].
Hamann KM; Faulhaber HD; Hamann B
Z Arztl Fortbild (Jena); 1982 Mar; 76(5):198-201. PubMed ID: 7080544
[TBL] [Abstract][Full Text] [Related]
13. Contraceptives, hypertension and renin.
Amorosa LF
N Engl J Med; 1972 May; 286(21):1163. PubMed ID: 5019655
[No Abstract] [Full Text] [Related]
14. Elevated prolactin levels in oral contraceptive pill-related hypertension.
Lehtovirta P; Ranta T; Seppälä M
Fertil Steril; 1981 Apr; 35(4):403-5. PubMed ID: 6783445
[TBL] [Abstract][Full Text] [Related]
15. Renal characteristics and effect of angiotensin suppression in oral contraceptive users.
Ribstein J; Halimi JM; du Cailar G; Mimran A
Hypertension; 1999 Jan; 33(1):90-5. PubMed ID: 9931087
[TBL] [Abstract][Full Text] [Related]
16. An increase in high-molecular weight renin substrate associated with estrogenic hypertension.
Shionoiri H; Eggena P; Barrett JD; Thananopavarn C; Golub MS; Eggena Z; Nakamura R; Judd HL; Sambhi MP
Biochem Med; 1983 Feb; 29(1):14-22. PubMed ID: 6838497
[TBL] [Abstract][Full Text] [Related]
17. [Effect of hormonal contraceptives on cardiovascular function].
Manuilova IA; Dubnitskaia LV; Trutko NS
Akush Ginekol (Mosk); 1983 Nov; (11):5-8. PubMed ID: 6364872
[TBL] [Abstract][Full Text] [Related]
18. Oestrogens and hypertension.
Roberts JM
Clin Endocrinol Metab; 1981 Nov; 10(3):489-512. PubMed ID: 7047019
[TBL] [Abstract][Full Text] [Related]
19. [Combined estrogen-progestagen contraception and glucid and water-sodium metabolism].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1988 Feb; 16(2):3-7. PubMed ID: 12342001
[TBL] [Abstract][Full Text] [Related]
20. [Oral contraceptives, hypertension and nephrosclerosis].
Girndt J
Fortschr Med; 1978 Feb; 96(7):327-32. PubMed ID: 627380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
